Next Article in Journal
IGF2BP3 Associates with Proliferative Phenotype and Prognostic Features in B-Cell Acute Lymphoblastic Leukemia
Previous Article in Journal
MAIT Cells: Partners or Enemies in Cancer Immunotherapy?
Previous Article in Special Issue
Infant Acute Myeloid Leukemia: A Unique Clinical and Biological Entity
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Editorial

Rare Childhood Malignancy

by
Elizabeth M Algar
1,2
1
Hudson Institute of Medical Research, Clayton 3168, Australia
2
Department of Translational Medicine, Monash University, Clayton 3168, Australia
Cancers 2021, 13(7), 1504; https://doi.org/10.3390/cancers13071504
Submission received: 24 February 2021 / Accepted: 8 March 2021 / Published: 25 March 2021
(This article belongs to the Special Issue Rare Childhood Malignancy)

Excerpt

Note: In lieu of an abstract, this is an excerpt from the first page.

This small collection of six original research papers and two review articles in the Special Issue “Rare Childhood Malignancy” highlights the diversity and importance of empirical research into childhood malignancy, a theme that underpins the significant advances that have been made in treating the diseases that constitute cancers in children [...]

Share and Cite

MDPI and ACS Style

Algar, E.M. Rare Childhood Malignancy. Cancers 2021, 13, 1504. https://doi.org/10.3390/cancers13071504

AMA Style

Algar EM. Rare Childhood Malignancy. Cancers. 2021; 13(7):1504. https://doi.org/10.3390/cancers13071504

Chicago/Turabian Style

Algar, Elizabeth M. 2021. "Rare Childhood Malignancy" Cancers 13, no. 7: 1504. https://doi.org/10.3390/cancers13071504

APA Style

Algar, E. M. (2021). Rare Childhood Malignancy. Cancers, 13(7), 1504. https://doi.org/10.3390/cancers13071504

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop